{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T01:47:45Z","timestamp":1782524865855,"version":"3.54.5"},"reference-count":72,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,1]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>Maximal resection of meningiomas is the gold standard of therapy, yet recurrence following surgery alone is fairly common, particularly with more aggressive tumors. The authors explored the efficacy of treatment of recurrent, aggressive meningiomas with resection plus Cs-131 collagen tile brachytherapy (R+CTBT).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>This was a prospective, nonrandomized, single-center trial that enrolled patients with recurrent aggressive meningiomas between June 2013 and January 2018. All patients underwent maximal safe resection and placement of Cs-131 tiles for CTBT. Local progression, defined as tumor recurrence within 1.5 cm of the operative bed, was determined on follow-up imaging, and hazard ratios were determined to compare the efficacy of R+CTBT with prior treatment at the same site.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>Twenty-nine recurrent aggressive meningiomas were treated in 27 patients with a median age of 66 (range 37\u201382) years. The WHO grade at the time of R+CTBT was grade 1 in 1 (3%) case, grade 2 in 26 (90%), and grade 3 in 2 (7%). The median radiographic follow-up was 34.8 (range 0.0\u201370.9) months. Local control at 48 and 60 months was 73% and 48%, respectively, following R+CTBT compared with 21% and 17% with prior treatment (HR 0.145, p &lt; 0.001). Surgery-related complications occurred in 4 cases (14%), including 1 case (3%) with early postoperative infection and 3 (10%) with delayed wound breakdown and infection. Radiation brain injury occurred in 4 cases (14%), and each resolved with medical therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>This study shows that resection combined with Cs-131 CTBT resulted in significantly improved local control with acceptable complications in patients with recurrent aggressive meningiomas when compared with the prior treatment at the same site.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3171\/2025.12.jns25868","type":"journal-article","created":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T02:03:30Z","timestamp":1777082610000},"page":"1-8","source":"Crossref","is-referenced-by-count":0,"title":["Resection and permanent intracranial brachytherapy using modular, biocompatible cesium-131 implants for recurrent aggressive meningiomas: 5-year results from a prospective phase 2 trial"],"prefix":"10.3171","author":[{"given":"Katriel E.","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Barrow Neurological Institute, St. Joseph\u2019s Hospital and Medical Center, Phoenix;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua S.","family":"Catapano","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Barrow Neurological Institute, St. Joseph\u2019s Hospital and Medical Center, Phoenix;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M.","family":"Eschbacher","sequence":"additional","affiliation":[{"name":"Department of Neuropathology, Barrow Neurological Institute, St. Joseph\u2019s Hospital and Medical Center, Phoenix, Arizona; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Leland","family":"Rogers","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Utah Cancer Specialists, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph M.","family":"Zabramski","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Barrow Neurological Institute, St. Joseph\u2019s Hospital and Medical Center, Phoenix;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"key":"b1","article-title":"NCCN clinical practice guidelines in oncology: central nervous system cancers","year":"2020","unstructured":"NCCN clinical practice guidelines in oncology: central nervous system cancers, version 2. 2020.Accessed February 4, 2026. http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/cns.pdf"},{"issue":"1","key":"b2","series-title":"J Neurosurg","first-page":"18","article-title":"Meningioma: analysis of recurrence and progression following neurosurgical resection","volume":"62","author":"Mirimanoff RO","year":"1985","unstructured":"Mirimanoff RO, Dosoretz DE, Linggood RM, Ojemann RG, Martuza RL. Meningioma: analysis of recurrence and progression following neurosurgical resection. J Neurosurg. 1985;62(1):18\u201324. doi:10.3171\/jns.1985.62.1.0018"},{"issue":"2","key":"b3","series-title":"J Neurooncol","first-page":"351","article-title":"Meningioma recurrence rates following treatment: a systematic analysis","volume":"136","author":"Lam Shin Cheung V","year":"2018","unstructured":"Lam Shin Cheung V, Kim A, Sahgal A, Das S. Meningioma recurrence rates following treatment: a systematic analysis. J Neurooncol. 2018;136(2):351\u2013361. doi:10.1007\/s11060-017-2659-6"},{"issue":"2","key":"b4","series-title":"J Neurooncol","first-page":"321","article-title":"Atypical and anaplastic meningioma: outcomes in a population based study","volume":"133","author":"Garzon-Muvdi T","year":"2017","unstructured":"Garzon-Muvdi T, Yang W, Lim M, Brem H, Huang J. Atypical and anaplastic meningioma: outcomes in a population based study. J Neurooncol. 2017;133(2):321\u2013330. doi:10.1007\/s11060-017-2436-6"},{"issue":"6","key":"b5","series-title":"Neurosurgery","first-page":"824","article-title":"Predictors of treatment response and survival outcomes in meningioma recurrence with atypical or anaplastic histology","volume":"82","author":"Chohan MO","year":"2018","unstructured":"Chohan MO, Ryan CT, Singh R,  Predictors of treatment response and survival outcomes in meningioma recurrence with atypical or anaplastic histology. Neurosurgery. 2018;82(6):824\u2013832. doi:10.1093\/neuros\/nyx312"},{"issue":"10","key":"b6","series-title":"Neuro Oncol","first-page":"1742","article-title":"Meningioma: International Consortium on Meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients","volume":"26","author":"Wang JZ","year":"2024","unstructured":"Wang JZ, Landry AP, Raleigh DR,  Meningioma: International Consortium on Meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients. Neuro Oncol. 2024;26(10):1742\u20131780. doi:10.1093\/neuonc\/noae082"},{"issue":"2","key":"b7","series-title":"Clin Transl Oncol","first-page":"205","article-title":"Role of adjuvant radiotherapy in atypical (WHO grade II) and anaplastic (WHO grade III) meningiomas: a systematic review","volume":"23","author":"Delgado-L\u00f3pez PD","year":"2021","unstructured":"Delgado-L\u00f3pez PD, Corrales-Garc\u00eda EM. Role of adjuvant radiotherapy in atypical (WHO grade II) and anaplastic (WHO grade III) meningiomas: a systematic review. Clin Transl Oncol. 2021;23(2):205\u2013221. doi:10.1007\/s12094-020-02434-3"},{"issue":"4","key":"b8","series-title":"Int J Radiat Oncol Biol Phys","first-page":"996","article-title":"Irradiated volume as a predictor of brain radionecrosis after linear accelerator stereotactic radiosurgery","volume":"77","author":"Blonigen BJ","year":"2010","unstructured":"Blonigen BJ, Steinmetz RD, Levin L, Lamba MA, Warnick RE, Breneman JC. Irradiated volume as a predictor of brain radionecrosis after linear accelerator stereotactic radiosurgery. Int J Radiat Oncol Biol Phys. 2010;77(4):996\u20131001. doi:10.1016\/j.ijrobp.2009.06.006"},{"issue":"6","key":"b9","series-title":"Neuro Oncol","first-page":"829","article-title":"Historical benchmarks for medical therapy trials in surgery- and radiation-refractory meningioma: a RANO review","volume":"16","author":"Kaley T","year":"2014","unstructured":"Kaley T, Barani I, Chamberlain M,  Historical benchmarks for medical therapy trials in surgery- and radiation-refractory meningioma: a RANO review. Neuro Oncol. 2014;16(6):829\u2013840. doi:10.1093\/neuonc\/not330"},{"issue":"24","key":"b10","series-title":"Cancer","first-page":"4376","article-title":"Extent of resection and overall survival for patients with atypical and malignant meningioma","volume":"121","author":"Aizer AA","year":"2015","unstructured":"Aizer AA, Bi WL, Kandola MS,  Extent of resection and overall survival for patients with atypical and malignant meningioma. Cancer. 2015;121(24):4376\u20134381. doi:10.1002\/cncr.29639"},{"issue":"4","key":"b11","series-title":"Cancer","first-page":"1048","article-title":"Stereotactic radiosurgery of World Health Organization grade II and III intracranial meningiomas: treatment results on the basis of a 22-year experience","volume":"118","author":"Pollock BE","year":"2012","unstructured":"Pollock BE, Stafford SL, Link MJ, Garces YI, Foote RL. Stereotactic radiosurgery of World Health Organization grade II and III intracranial meningiomas: treatment results on the basis of a 22-year experience. Cancer. 2012;118(4):1048\u20131054. doi:10.1002\/cncr.26362"},{"issue":"5","key":"b12","series-title":"Health Phys","first-page":"666","article-title":"Dose to normal tissues outside the radiation therapy patient\u2019s treated volume: a review of different radiation therapy techniques","volume":"95","author":"Purdy JA","year":"2008","unstructured":"Purdy JA. Dose to normal tissues outside the radiation therapy patient\u2019s treated volume: a review of different radiation therapy techniques. Health Phys. 2008;95(5):666\u2013676. doi:10.1097\/01.HP.0000326342.47348.06"},{"issue":"6","key":"b13","series-title":"J Neurosurg","first-page":"1819","article-title":"Resection and permanent intracranial brachytherapy using modular, biocompatible cesium-131 implants: results in 20 recurrent, previously irradiated meningiomas","volume":"131","author":"Brachman DG","year":"2019","unstructured":"Brachman DG, Youssef E, Dardis CJ,  Resection and permanent intracranial brachytherapy using modular, biocompatible cesium-131 implants: results in 20 recurrent, previously irradiated meningiomas. J Neurosurg. 2019;131(6):1819\u20131828. doi:10.3171\/2018.7.JNS18656"},{"issue":"1","key":"b14","series-title":"J Neurooncol","first-page":"63","article-title":"Neurocognitive function and quality of life in patients with newly diagnosed brain metastasis after treatment with intra-operative cesium-131 brachytherapy: a prospective trial","volume":"127","author":"Pham A","year":"2016","unstructured":"Pham A, Yondorf MZ, Parashar B,  Neurocognitive function and quality of life in patients with newly diagnosed brain metastasis after treatment with intra-operative cesium-131 brachytherapy: a prospective trial. J Neurooncol. 2016;127(1):63\u201371. doi:10.1007\/s11060-015-2009-5"},{"issue":"3","key":"b15","series-title":"Neurosurg Focus","first-page":"E3","article-title":"Management of newly diagnosed single brain metastasis using resection and permanent iodine-125 seeds without initial whole-brain radiotherapy: a two institution experience","volume":"22","author":"Dagnew E","year":"2007","unstructured":"Dagnew E, Kanski J, McDermott MW,  Management of newly diagnosed single brain metastasis using resection and permanent iodine-125 seeds without initial whole-brain radiotherapy: a two institution experience. Neurosurg Focus. 2007;22(3):E3. doi:10.3171\/foc.2007.22.3.4"},{"issue":"5","key":"b16","series-title":"Neurosurgery","first-page":"E910","article-title":"Brachytherapy as an adjuvant for recurrent atypical and malignant meningiomas","volume":"85","author":"Koch MJ","year":"2019","unstructured":"Koch MJ, Agarwalla PK, Royce TJ,  Brachytherapy as an adjuvant for recurrent atypical and malignant meningiomas. Neurosurgery. 2019;85(5):E910\u2013E916. doi:10.1093\/neuros\/nyz115"},{"issue":"3","key":"b17","series-title":"Neurosurgery","first-page":"409","article-title":"Surgical resection and interstitial iodine-125 brachytherapy for high-grade meningiomas: a 25-year series","volume":"80","author":"Magill ST","year":"2017","unstructured":"Magill ST, Lau D, Raleigh DR, Sneed PK, Fogh SE, McDermott MW. Surgical resection and interstitial iodine-125 brachytherapy for high-grade meningiomas: a 25-year series. Neurosurgery. 2017;80(3):409\u2013416. doi:10.1227\/NEU.0000000000001262"},{"issue":"1","key":"b18","series-title":"J Neurooncol","first-page":"111","article-title":"Brachytherapy with surgical resection as salvage treatment for recurrent high-grade meningiomas: a matched cohort study","volume":"146","author":"Mooney MA","year":"2020","unstructured":"Mooney MA, Bi WL, Cantalino JM,  Brachytherapy with surgical resection as salvage treatment for recurrent high-grade meningiomas: a matched cohort study. J Neurooncol. 2020;146(1):111\u2013120. doi:10.1007\/s11060-019-03342-5"},{"issue":"8","key":"b19","series-title":"Cureus","first-page":"e9666","article-title":"Re-irradiation using brachytherapy for recurrent intracranial tumors: a systematic review and meta-analysis of the literature","volume":"12","author":"Choi M","year":"2020","unstructured":"Choi M, Zabramski JM. Re-irradiation using brachytherapy for recurrent intracranial tumors: a systematic review and meta-analysis of the literature. Cureus. 2020;12(8):e9666. doi:10.7759\/cureus.9666"},{"issue":"11","key":"b20","series-title":"J Clin Oncol","first-page":"1963","article-title":"Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group","volume":"28","author":"Wen PY","year":"2010","unstructured":"Wen PY, Macdonald DR, Reardon DA,  Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol. 2010;28(11):1963\u20131972. doi:10.1200\/JCO.2009.26.3541"},{"key":"b21","article-title":"Common Terminology Criteria for Adverse Events (CTCAE)","year":"2017","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE). Version 5.0 (2017). Accessed February 4, 2026. https:\/\/dctd.cancer.gov\/research\/ctep-trials\/for-sites\/adverse-events\/ctcae-v5-5x7.pdf"},{"issue":"2","key":"b22","series-title":"(EORTC 22042-26042).","first-page":"260","article-title":"Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma: a phase-II parallel non-randomized and observation study","volume":"128","author":"Weber DC","year":"2018","unstructured":"Weber DC, Ares C, Villa S,  Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma: a phase-II parallel non-randomized and observation study. (EORTC 22042-26042).Radiother Oncol. 2018;128(2):260\u2013265. doi:10.1016\/j.radonc.2018.06.018"},{"issue":"4","key":"b23","series-title":"Int J Radiat Oncol Biol Phys","first-page":"790","article-title":"High-risk meningioma: initial outcomes from NRG Oncology\/RTOG 0539","volume":"106","author":"Rogers CL","year":"2020","unstructured":"Rogers CL, Won M, Vogelbaum MA,  High-risk meningioma: initial outcomes from NRG Oncology\/RTOG 0539. Int J Radiat Oncol Biol Phys. 2020;106(4):790\u2013799. doi:10.1016\/j.ijrobp.2019.11.028"},{"issue":"11","key":"b24","series-title":"Strahlenther Onkol","first-page":"921","article-title":"High-precision radiotherapy for meningiomas: long-term results and patient-reported outcome (PRO)","volume":"193","author":"Kessel KA","year":"2017","unstructured":"Kessel KA, Fischer H, Oechnser M, Zimmer C, Meyer B, Combs SE. High-precision radiotherapy for meningiomas: long-term results and patient-reported outcome (PRO). Strahlenther Onkol. 2017;193(11):921\u2013930. doi:10.1007\/s00066-017-1156-3"},{"key":"b25","series-title":"World Neurosurg","first-page":"565","article-title":"Recurrent atypical meningiomas: combining surgery and radiosurgery in one effective multimodal treatment","volume":"87","author":"Talacchi A","year":"2016","unstructured":"Talacchi A, Muggiolu F, De Carlo A, Nicolato A, Locatelli F, Meglio M. Recurrent atypical meningiomas: combining surgery and radiosurgery in one effective multimodal treatment. World Neurosurg. 2016;87:565\u2013572. doi:10.1016\/j.wneu.2015.10.013"},{"key":"b26","series-title":"World Neurosurg","first-page":"139","article-title":"Clinical outcome, tumor recurrence, and causes of death: a long-term follow-up of surgically treated meningiomas","volume":"102","author":"de Almeida AN","year":"2017","unstructured":"de Almeida AN, Pereira BJA, Pires Aguiar PH,  Clinical outcome, tumor recurrence, and causes of death: a long-term follow-up of surgically treated meningiomas. World Neurosurg. 2017;102:139\u2013143. doi:10.1016\/j.wneu.2017.03.009"},{"issue":"6","key":"b27","series-title":"World Neurosurg","first-page":"564","article-title":"Long-term 25-year follow-up of surgically treated parasagittal meningiomas","volume":"76","author":"Pettersson-Segerlind J","year":"2011","unstructured":"Pettersson-Segerlind J, Orrego A, Lonn S, Mathiesen T. Long-term 25-year follow-up of surgically treated parasagittal meningiomas. World Neurosurg. 2011;76(6):564\u2013571. doi:10.1016\/j.wneu.2011.05.015"},{"issue":"5","key":"b28","series-title":"Neuro Oncol","first-page":"628","article-title":"Adjuvant radiotherapy for atypical and malignant meningiomas: a systematic review","volume":"16","author":"Kaur G","year":"2014","unstructured":"Kaur G, Sayegh ET, Larson A,  Adjuvant radiotherapy for atypical and malignant meningiomas: a systematic review. Neuro Oncol. 2014;16(5):628\u2013636. doi:10.1093\/neuonc\/nou025"},{"issue":"3","key":"b29","series-title":"J Neurooncol","first-page":"393","article-title":"Brachytherapy for central nervous system tumors","volume":"158","author":"Bander ED","year":"2022","unstructured":"Bander ED, Knisely JPS, Schwartz TH. Brachytherapy for central nervous system tumors. J Neurooncol. 2022;158(3):393\u2013403. doi:10.1007\/s11060-022-04026-3"},{"issue":"2","key":"b30","series-title":"J Neurooncol","first-page":"355","article-title":"Safety and efficacy of Cesium-131 brachytherapy for brain tumors","volume":"163","author":"Bander ED","year":"2023","unstructured":"Bander ED, Kelly A, Ma X,  Safety and efficacy of Cesium-131 brachytherapy for brain tumors. J Neurooncol. 2023;163(2):355\u2013365. doi:10.1007\/s11060-023-04352-0"},{"issue":"1","key":"b31","series-title":"Oper Neurosurg","first-page":"49","article-title":"Surgical technique and clinically relevant resection cavity dynamics following implantation of Cesium-131 (Cs-131) brachytherapy in patients with brain metastases","volume":"12","author":"Wernicke AG","year":"2016","unstructured":"Wernicke AG, Lazow SP, Taube S,  Surgical technique and clinically relevant resection cavity dynamics following implantation of Cesium-131 (Cs-131) brachytherapy in patients with brain metastases. Oper Neurosurg. 2016;12(1):49\u201360. doi:10.1227\/NEU.0000000000000986"},{"issue":"2","key":"b32","series-title":"Int J Radiat Oncol Biol Phys","first-page":"S755","article-title":"Dosimetric cmparison of Cs-131 versus I-125 intraoperative brachytherapy for patients with resected brain metastasis renders Cs-131 more sparing of normal brain tissue: clinical relevance for prevention of radiation necrosis from a prospective trial","volume":"87","author":"Nedialkova L","year":"2013","unstructured":"Nedialkova L, Sabbas A, Trichter S,  Dosimetric cmparison of Cs-131 versus I-125 intraoperative brachytherapy for patients with resected brain metastasis renders Cs-131 more sparing of normal brain tissue: clinical relevance for prevention of radiation necrosis from a prospective trial. Int J Radiat Oncol Biol Phys. 2013;87(2):S755\u2013S756. doi:10.1016\/j.ijrobp.2013.06.2002"},{"issue":"4","key":"b33","series-title":"J Neurosurg","first-page":"924","article-title":"Resection with intraoperative cesium-131 brachytherapy as salvage therapy for recurrent brain tumors","volume":"137","author":"Chen WC","year":"2022","unstructured":"Chen WC, Lafreniere M, Phuong C,  Resection with intraoperative cesium-131 brachytherapy as salvage therapy for recurrent brain tumors. J Neurosurg. 2022;137(4):924\u2013930. doi:10.3171\/2021.10.JNS211886"},{"issue":"3","key":"b34","series-title":"Brachytherapy","first-page":"S35","article-title":"Surgically targeted radiation therapy: safety profile of collagen tile brachytherapy in 79 recurrent, previously irradiated intracranial neoplasms on a prospective clinical trial","volume":"18","author":"Brachman D","year":"2019","unstructured":"Brachman D, Youssef E, Dardis C, Smith K, Pinnaduwage D, Nakaji P. Surgically targeted radiation therapy: safety profile of collagen tile brachytherapy in 79 recurrent, previously irradiated intracranial neoplasms on a prospective clinical trial. Brachytherapy. 2019;18(3):S35\u2013S36. doi:10.1016\/j.brachy.2019.04.076"},{"issue":"9","key":"b35","series-title":"Med Phys","first-page":"e297","article-title":"Supplement 2 for the 2004 update of the AAPM Task Group No. 43 Report: joint recommendations by the AAPM and GEC-ESTRO","volume":"44","author":"Rivard MJ","year":"2017","unstructured":"Rivard MJ, Ballester F, Butler WM,  Supplement 2 for the 2004 update of the AAPM Task Group No. 43 Report: joint recommendations by the AAPM and GEC-ESTRO. Med Phys. 2017;44(9):e297\u2013e338. doi:10.1002\/mp.12430"},{"issue":"4","key":"b36","series-title":"J Neurosurg","first-page":"1212","article-title":"Cesium-131 brachytherapy for recurrent brain metastases: durable salvage treatment for previously irradiated metastatic disease","volume":"126","author":"Wernicke AG","year":"2017","unstructured":"Wernicke AG, Smith AW, Taube S,  Cesium-131 brachytherapy for recurrent brain metastases: durable salvage treatment for previously irradiated metastatic disease. J Neurosurg. 2017;126(4):1212\u20131219. doi:10.3171\/2016.3.JNS152836"},{"key":"b1","article-title":"NCCN clinical practice guidelines in oncology: central nervous system cancers","year":"2020","unstructured":"NCCN clinical practice guidelines in oncology: central nervous system cancers, version 2. 2020.Accessed February 4, 2026. http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/cns.pdf"},{"issue":"1","key":"b2","series-title":"J Neurosurg","first-page":"18","article-title":"Meningioma: analysis of recurrence and progression following neurosurgical resection","volume":"62","author":"Mirimanoff RO","year":"1985","unstructured":"Mirimanoff RO, Dosoretz DE, Linggood RM, Ojemann RG, Martuza RL. Meningioma: analysis of recurrence and progression following neurosurgical resection. J Neurosurg. 1985;62(1):18\u201324. doi:10.3171\/jns.1985.62.1.0018"},{"issue":"2","key":"b3","series-title":"J Neurooncol","first-page":"351","article-title":"Meningioma recurrence rates following treatment: a systematic analysis","volume":"136","author":"Lam Shin Cheung V","year":"2018","unstructured":"Lam Shin Cheung V, Kim A, Sahgal A, Das S. Meningioma recurrence rates following treatment: a systematic analysis. J Neurooncol. 2018;136(2):351\u2013361. doi:10.1007\/s11060-017-2659-6"},{"issue":"2","key":"b4","series-title":"J Neurooncol","first-page":"321","article-title":"Atypical and anaplastic meningioma: outcomes in a population based study","volume":"133","author":"Garzon-Muvdi T","year":"2017","unstructured":"Garzon-Muvdi T, Yang W, Lim M, Brem H, Huang J. Atypical and anaplastic meningioma: outcomes in a population based study. J Neurooncol. 2017;133(2):321\u2013330. doi:10.1007\/s11060-017-2436-6"},{"issue":"6","key":"b5","series-title":"Neurosurgery","first-page":"824","article-title":"Predictors of treatment response and survival outcomes in meningioma recurrence with atypical or anaplastic histology","volume":"82","author":"Chohan MO","year":"2018","unstructured":"Chohan MO, Ryan CT, Singh R,  Predictors of treatment response and survival outcomes in meningioma recurrence with atypical or anaplastic histology. Neurosurgery. 2018;82(6):824\u2013832. doi:10.1093\/neuros\/nyx312"},{"issue":"10","key":"b6","series-title":"Neuro Oncol","first-page":"1742","article-title":"Meningioma: International Consortium on Meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients","volume":"26","author":"Wang JZ","year":"2024","unstructured":"Wang JZ, Landry AP, Raleigh DR,  Meningioma: International Consortium on Meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients. Neuro Oncol. 2024;26(10):1742\u20131780. doi:10.1093\/neuonc\/noae082"},{"issue":"2","key":"b7","series-title":"Clin Transl Oncol","first-page":"205","article-title":"Role of adjuvant radiotherapy in atypical (WHO grade II) and anaplastic (WHO grade III) meningiomas: a systematic review","volume":"23","author":"Delgado-L\u00f3pez PD","year":"2021","unstructured":"Delgado-L\u00f3pez PD, Corrales-Garc\u00eda EM. Role of adjuvant radiotherapy in atypical (WHO grade II) and anaplastic (WHO grade III) meningiomas: a systematic review. Clin Transl Oncol. 2021;23(2):205\u2013221. doi:10.1007\/s12094-020-02434-3"},{"issue":"4","key":"b8","series-title":"Int J Radiat Oncol Biol Phys","first-page":"996","article-title":"Irradiated volume as a predictor of brain radionecrosis after linear accelerator stereotactic radiosurgery","volume":"77","author":"Blonigen BJ","year":"2010","unstructured":"Blonigen BJ, Steinmetz RD, Levin L, Lamba MA, Warnick RE, Breneman JC. Irradiated volume as a predictor of brain radionecrosis after linear accelerator stereotactic radiosurgery. Int J Radiat Oncol Biol Phys. 2010;77(4):996\u20131001. doi:10.1016\/j.ijrobp.2009.06.006"},{"issue":"6","key":"b9","series-title":"Neuro Oncol","first-page":"829","article-title":"Historical benchmarks for medical therapy trials in surgery- and radiation-refractory meningioma: a RANO review","volume":"16","author":"Kaley T","year":"2014","unstructured":"Kaley T, Barani I, Chamberlain M,  Historical benchmarks for medical therapy trials in surgery- and radiation-refractory meningioma: a RANO review. Neuro Oncol. 2014;16(6):829\u2013840. doi:10.1093\/neuonc\/not330"},{"issue":"24","key":"b10","series-title":"Cancer","first-page":"4376","article-title":"Extent of resection and overall survival for patients with atypical and malignant meningioma","volume":"121","author":"Aizer AA","year":"2015","unstructured":"Aizer AA, Bi WL, Kandola MS,  Extent of resection and overall survival for patients with atypical and malignant meningioma. Cancer. 2015;121(24):4376\u20134381. doi:10.1002\/cncr.29639"},{"issue":"4","key":"b11","series-title":"Cancer","first-page":"1048","article-title":"Stereotactic radiosurgery of World Health Organization grade II and III intracranial meningiomas: treatment results on the basis of a 22-year experience","volume":"118","author":"Pollock BE","year":"2012","unstructured":"Pollock BE, Stafford SL, Link MJ, Garces YI, Foote RL. Stereotactic radiosurgery of World Health Organization grade II and III intracranial meningiomas: treatment results on the basis of a 22-year experience. Cancer. 2012;118(4):1048\u20131054. doi:10.1002\/cncr.26362"},{"issue":"5","key":"b12","series-title":"Health Phys","first-page":"666","article-title":"Dose to normal tissues outside the radiation therapy patient\u2019s treated volume: a review of different radiation therapy techniques","volume":"95","author":"Purdy JA","year":"2008","unstructured":"Purdy JA. Dose to normal tissues outside the radiation therapy patient\u2019s treated volume: a review of different radiation therapy techniques. Health Phys. 2008;95(5):666\u2013676. doi:10.1097\/01.HP.0000326342.47348.06"},{"issue":"6","key":"b13","series-title":"J Neurosurg","first-page":"1819","article-title":"Resection and permanent intracranial brachytherapy using modular, biocompatible cesium-131 implants: results in 20 recurrent, previously irradiated meningiomas","volume":"131","author":"Brachman DG","year":"2019","unstructured":"Brachman DG, Youssef E, Dardis CJ,  Resection and permanent intracranial brachytherapy using modular, biocompatible cesium-131 implants: results in 20 recurrent, previously irradiated meningiomas. J Neurosurg. 2019;131(6):1819\u20131828. doi:10.3171\/2018.7.JNS18656"},{"issue":"1","key":"b14","series-title":"J Neurooncol","first-page":"63","article-title":"Neurocognitive function and quality of life in patients with newly diagnosed brain metastasis after treatment with intra-operative cesium-131 brachytherapy: a prospective trial","volume":"127","author":"Pham A","year":"2016","unstructured":"Pham A, Yondorf MZ, Parashar B,  Neurocognitive function and quality of life in patients with newly diagnosed brain metastasis after treatment with intra-operative cesium-131 brachytherapy: a prospective trial. J Neurooncol. 2016;127(1):63\u201371. doi:10.1007\/s11060-015-2009-5"},{"issue":"3","key":"b15","series-title":"Neurosurg Focus","first-page":"E3","article-title":"Management of newly diagnosed single brain metastasis using resection and permanent iodine-125 seeds without initial whole-brain radiotherapy: a two institution experience","volume":"22","author":"Dagnew E","year":"2007","unstructured":"Dagnew E, Kanski J, McDermott MW,  Management of newly diagnosed single brain metastasis using resection and permanent iodine-125 seeds without initial whole-brain radiotherapy: a two institution experience. Neurosurg Focus. 2007;22(3):E3. doi:10.3171\/foc.2007.22.3.4"},{"issue":"5","key":"b16","series-title":"Neurosurgery","first-page":"E910","article-title":"Brachytherapy as an adjuvant for recurrent atypical and malignant meningiomas","volume":"85","author":"Koch MJ","year":"2019","unstructured":"Koch MJ, Agarwalla PK, Royce TJ,  Brachytherapy as an adjuvant for recurrent atypical and malignant meningiomas. Neurosurgery. 2019;85(5):E910\u2013E916. doi:10.1093\/neuros\/nyz115"},{"issue":"3","key":"b17","series-title":"Neurosurgery","first-page":"409","article-title":"Surgical resection and interstitial iodine-125 brachytherapy for high-grade meningiomas: a 25-year series","volume":"80","author":"Magill ST","year":"2017","unstructured":"Magill ST, Lau D, Raleigh DR, Sneed PK, Fogh SE, McDermott MW. Surgical resection and interstitial iodine-125 brachytherapy for high-grade meningiomas: a 25-year series. Neurosurgery. 2017;80(3):409\u2013416. doi:10.1227\/NEU.0000000000001262"},{"issue":"1","key":"b18","series-title":"J Neurooncol","first-page":"111","article-title":"Brachytherapy with surgical resection as salvage treatment for recurrent high-grade meningiomas: a matched cohort study","volume":"146","author":"Mooney MA","year":"2020","unstructured":"Mooney MA, Bi WL, Cantalino JM,  Brachytherapy with surgical resection as salvage treatment for recurrent high-grade meningiomas: a matched cohort study. J Neurooncol. 2020;146(1):111\u2013120. doi:10.1007\/s11060-019-03342-5"},{"issue":"8","key":"b19","series-title":"Cureus","first-page":"e9666","article-title":"Re-irradiation using brachytherapy for recurrent intracranial tumors: a systematic review and meta-analysis of the literature","volume":"12","author":"Choi M","year":"2020","unstructured":"Choi M, Zabramski JM. Re-irradiation using brachytherapy for recurrent intracranial tumors: a systematic review and meta-analysis of the literature. Cureus. 2020;12(8):e9666. doi:10.7759\/cureus.9666"},{"issue":"11","key":"b20","series-title":"J Clin Oncol","first-page":"1963","article-title":"Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group","volume":"28","author":"Wen PY","year":"2010","unstructured":"Wen PY, Macdonald DR, Reardon DA,  Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol. 2010;28(11):1963\u20131972. doi:10.1200\/JCO.2009.26.3541"},{"key":"b21","article-title":"Common Terminology Criteria for Adverse Events (CTCAE)","year":"2017","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE). Version 5.0 (2017). Accessed February 4, 2026. https:\/\/dctd.cancer.gov\/research\/ctep-trials\/for-sites\/adverse-events\/ctcae-v5-5x7.pdf"},{"issue":"2","key":"b22","series-title":"(EORTC 22042-26042).","first-page":"260","article-title":"Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma: a phase-II parallel non-randomized and observation study","volume":"128","author":"Weber DC","year":"2018","unstructured":"Weber DC, Ares C, Villa S,  Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma: a phase-II parallel non-randomized and observation study. (EORTC 22042-26042).Radiother Oncol. 2018;128(2):260\u2013265. doi:10.1016\/j.radonc.2018.06.018"},{"issue":"4","key":"b23","series-title":"Int J Radiat Oncol Biol Phys","first-page":"790","article-title":"High-risk meningioma: initial outcomes from NRG Oncology\/RTOG 0539","volume":"106","author":"Rogers CL","year":"2020","unstructured":"Rogers CL, Won M, Vogelbaum MA,  High-risk meningioma: initial outcomes from NRG Oncology\/RTOG 0539. Int J Radiat Oncol Biol Phys. 2020;106(4):790\u2013799. doi:10.1016\/j.ijrobp.2019.11.028"},{"issue":"11","key":"b24","series-title":"Strahlenther Onkol","first-page":"921","article-title":"High-precision radiotherapy for meningiomas: long-term results and patient-reported outcome (PRO)","volume":"193","author":"Kessel KA","year":"2017","unstructured":"Kessel KA, Fischer H, Oechnser M, Zimmer C, Meyer B, Combs SE. High-precision radiotherapy for meningiomas: long-term results and patient-reported outcome (PRO). Strahlenther Onkol. 2017;193(11):921\u2013930. doi:10.1007\/s00066-017-1156-3"},{"key":"b25","series-title":"World Neurosurg","first-page":"565","article-title":"Recurrent atypical meningiomas: combining surgery and radiosurgery in one effective multimodal treatment","volume":"87","author":"Talacchi A","year":"2016","unstructured":"Talacchi A, Muggiolu F, De Carlo A, Nicolato A, Locatelli F, Meglio M. Recurrent atypical meningiomas: combining surgery and radiosurgery in one effective multimodal treatment. World Neurosurg. 2016;87:565\u2013572. doi:10.1016\/j.wneu.2015.10.013"},{"key":"b26","series-title":"World Neurosurg","first-page":"139","article-title":"Clinical outcome, tumor recurrence, and causes of death: a long-term follow-up of surgically treated meningiomas","volume":"102","author":"de Almeida AN","year":"2017","unstructured":"de Almeida AN, Pereira BJA, Pires Aguiar PH,  Clinical outcome, tumor recurrence, and causes of death: a long-term follow-up of surgically treated meningiomas. World Neurosurg. 2017;102:139\u2013143. doi:10.1016\/j.wneu.2017.03.009"},{"issue":"6","key":"b27","series-title":"World Neurosurg","first-page":"564","article-title":"Long-term 25-year follow-up of surgically treated parasagittal meningiomas","volume":"76","author":"Pettersson-Segerlind J","year":"2011","unstructured":"Pettersson-Segerlind J, Orrego A, Lonn S, Mathiesen T. Long-term 25-year follow-up of surgically treated parasagittal meningiomas. World Neurosurg. 2011;76(6):564\u2013571. doi:10.1016\/j.wneu.2011.05.015"},{"issue":"5","key":"b28","series-title":"Neuro Oncol","first-page":"628","article-title":"Adjuvant radiotherapy for atypical and malignant meningiomas: a systematic review","volume":"16","author":"Kaur G","year":"2014","unstructured":"Kaur G, Sayegh ET, Larson A,  Adjuvant radiotherapy for atypical and malignant meningiomas: a systematic review. Neuro Oncol. 2014;16(5):628\u2013636. doi:10.1093\/neuonc\/nou025"},{"issue":"3","key":"b29","series-title":"J Neurooncol","first-page":"393","article-title":"Brachytherapy for central nervous system tumors","volume":"158","author":"Bander ED","year":"2022","unstructured":"Bander ED, Knisely JPS, Schwartz TH. Brachytherapy for central nervous system tumors. J Neurooncol. 2022;158(3):393\u2013403. doi:10.1007\/s11060-022-04026-3"},{"issue":"2","key":"b30","series-title":"J Neurooncol","first-page":"355","article-title":"Safety and efficacy of Cesium-131 brachytherapy for brain tumors","volume":"163","author":"Bander ED","year":"2023","unstructured":"Bander ED, Kelly A, Ma X,  Safety and efficacy of Cesium-131 brachytherapy for brain tumors. J Neurooncol. 2023;163(2):355\u2013365. doi:10.1007\/s11060-023-04352-0"},{"issue":"1","key":"b31","series-title":"Oper Neurosurg","first-page":"49","article-title":"Surgical technique and clinically relevant resection cavity dynamics following implantation of Cesium-131 (Cs-131) brachytherapy in patients with brain metastases","volume":"12","author":"Wernicke AG","year":"2016","unstructured":"Wernicke AG, Lazow SP, Taube S,  Surgical technique and clinically relevant resection cavity dynamics following implantation of Cesium-131 (Cs-131) brachytherapy in patients with brain metastases. Oper Neurosurg. 2016;12(1):49\u201360. doi:10.1227\/NEU.0000000000000986"},{"issue":"2","key":"b32","series-title":"Int J Radiat Oncol Biol Phys","first-page":"S755","article-title":"Dosimetric cmparison of Cs-131 versus I-125 intraoperative brachytherapy for patients with resected brain metastasis renders Cs-131 more sparing of normal brain tissue: clinical relevance for prevention of radiation necrosis from a prospective trial","volume":"87","author":"Nedialkova L","year":"2013","unstructured":"Nedialkova L, Sabbas A, Trichter S,  Dosimetric cmparison of Cs-131 versus I-125 intraoperative brachytherapy for patients with resected brain metastasis renders Cs-131 more sparing of normal brain tissue: clinical relevance for prevention of radiation necrosis from a prospective trial. Int J Radiat Oncol Biol Phys. 2013;87(2):S755\u2013S756. doi:10.1016\/j.ijrobp.2013.06.2002"},{"issue":"4","key":"b33","series-title":"J Neurosurg","first-page":"924","article-title":"Resection with intraoperative cesium-131 brachytherapy as salvage therapy for recurrent brain tumors","volume":"137","author":"Chen WC","year":"2022","unstructured":"Chen WC, Lafreniere M, Phuong C,  Resection with intraoperative cesium-131 brachytherapy as salvage therapy for recurrent brain tumors. J Neurosurg. 2022;137(4):924\u2013930. doi:10.3171\/2021.10.JNS211886"},{"issue":"3","key":"b34","series-title":"Brachytherapy","first-page":"S35","article-title":"Surgically targeted radiation therapy: safety profile of collagen tile brachytherapy in 79 recurrent, previously irradiated intracranial neoplasms on a prospective clinical trial","volume":"18","author":"Brachman D","year":"2019","unstructured":"Brachman D, Youssef E, Dardis C, Smith K, Pinnaduwage D, Nakaji P. Surgically targeted radiation therapy: safety profile of collagen tile brachytherapy in 79 recurrent, previously irradiated intracranial neoplasms on a prospective clinical trial. Brachytherapy. 2019;18(3):S35\u2013S36. doi:10.1016\/j.brachy.2019.04.076"},{"issue":"9","key":"b35","series-title":"Med Phys","first-page":"e297","article-title":"Supplement 2 for the 2004 update of the AAPM Task Group No. 43 Report: joint recommendations by the AAPM and GEC-ESTRO","volume":"44","author":"Rivard MJ","year":"2017","unstructured":"Rivard MJ, Ballester F, Butler WM,  Supplement 2 for the 2004 update of the AAPM Task Group No. 43 Report: joint recommendations by the AAPM and GEC-ESTRO. Med Phys. 2017;44(9):e297\u2013e338. doi:10.1002\/mp.12430"},{"issue":"4","key":"b36","series-title":"J Neurosurg","first-page":"1212","article-title":"Cesium-131 brachytherapy for recurrent brain metastases: durable salvage treatment for previously irradiated metastatic disease","volume":"126","author":"Wernicke AG","year":"2017","unstructured":"Wernicke AG, Smith AW, Taube S,  Cesium-131 brachytherapy for recurrent brain metastases: durable salvage treatment for previously irradiated metastatic disease. J Neurosurg. 2017;126(4):1212\u20131219. doi:10.3171\/2016.3.JNS152836"}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/aop\/article-10.3171-2025.12.JNS25868\/article-10.3171-2025.12.JNS25868.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/aop\/article-10.3171-2025.12.JNS25868\/article-10.3171-2025.12.JNS25868.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/aop\/article-10.3171-2025.12.JNS25868\/article-10.3171-2025.12.JNS25868.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T01:38:28Z","timestamp":1782524308000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/aop\/article-10.3171-2025.12.JNS25868\/article-10.3171-2025.12.JNS25868.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":72,"URL":"https:\/\/doi.org\/10.3171\/2025.12.jns25868","relation":{},"ISSN":["0022-3085","1933-0693"],"issn-type":[{"value":"0022-3085","type":"print"},{"value":"1933-0693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]}}}